Af de 271 patienter, som fik romiplostim i de kliniske undersøgelser vedrørende ITP, var 55 (20%) 65 år eller derover, og 27 (10%) var 75 år eller derover.
Of the 271 patients who received romiplostim in ITP clinical studies, 55 (20%) were age 65 and over, and 27 (10%) were 75 and over.